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Methylmalonic aciduria can occur to a widely varying
degree, in isolation or combined with homocystinuria
in a range of conditions. These include absorption and
transport disorders or defects of intracellular cellular
metabolism of vitamin B12, nutritional deficiency of
this vitamin, or genetic defects of methylmalonyl-CoA
mutase. Recent advances have elucidated the genes
and mutations responsible for most of these disorders.
The biochemically and genetically defined methyl-
malonic acidurias constitute an important group of
potentially treatable disorders with still major diag-
nostic and management challenges. Furthermore, less
well defined milder methylmalonic aciduria has re-
cently been shown in some cases to be associated with
SUCL mutations or methylmalonyl-CoA epimerase
deficiency.
It is therefore timely and opportune that the editors
of this Journal have chosen to publish two series of
papers on this topic.
The articles which appear in this issue include the
review BNeurodegeneration and chronic renal failure
in methylmalonic aciduria—A pathophysiological
approach^ by Marina Morath and colleagues. This
proposes and examines interesting and plausible hy-
potheses on pathogenetic mechanisms about which
little is known. The original article BMethylmalonate
inhibits succinate-supported oxygen consumption by
interfering with mitochondrial succinate uptake^ by
Sandra Mirandola and colleagues reports interesting
evidence of a possible patho-physiological role of
methylmalonic acid in inhibition of succinate uptake
in rat brain or muscle mitochondria. The original
article BMethylmalonic acidaemia: Examination of
genotype and biochemical data in 32 patients belong-
ing to mut, cblA or cblB complementation group^ by
Begona Merinero and colleagues reports an interesting
critical comparison of in vivo and in vitro biochemical
parameters with the nature of mutations in different
complementation groups.
The follow-up series will include mainly review
articles (planned for issue 3, 2008) and will cover the
following:
& Isolated methylmalonic acidurias in European
metabolic centres (Hoerster et al)
& A review of the spectrum of MRI changes in
methylmalonic aciduria (Harting et al)
& The comprehensive diagnostic approach for the
reliable characterization of patients with isolated
methylmalonic aciduria (Fowler et al)
& Present knowledge of potential and experience of
newborn screening for the methylmalonic acidurias
(Lindner et al).
We hope this series of articles will provide a solid
basis to underscore further developments in this field
and will serve to support future much needed prospec-
tive studies and recommendations aimed at improving
the long term outcome of these life-threatening
disorders.
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